recurrent non small cell lung cancer
Showing 1 - 7 of 7
Non Small Cell Lung Cancer, Metastatic NSCLC, Recurrent Non Small Cell Lung Cancer Trial (Pembrolizumab, GT103)
Not yet recruiting
- Non Small Cell Lung Cancer
- +2 more
- (no location specified)
Jan 12, 2023
Non Small Cell Lung Cancer, Stage IV NSCLC, Recurrent Non Small Cell Lung Cancer Trial in Tampa (biological, drug, other)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Tumor-infiltrating Lymphocytes (TIL)
- +5 more
-
Tampa, FloridaMoffitt Cancer Center
Dec 28, 2022
NSCLC, NSCLC Stage III, Recurrent Non Small Cell Lung Cancer Trial (Garmin Vivofit Activity Tracker)
Not yet recruiting
- Non-small Cell Lung Cancer
- +2 more
- Garmin Vivofit Activity Tracker
- (no location specified)
Aug 31, 2022
Metastatic Non Small Cell Lung Cancer, Recurrent Non Small Cell Lung Cancer Trial in United States (Amivantamab, Lazertinib)
Recruiting
- Metastatic Non Small Cell Lung Cancer
- Recurrent Non Small Cell Lung Cancer
-
Basking Ridge, New Jersey
- +6 more
Aug 1, 2022
Metastatic Non Small Cell Lung Cancer, Recurrent Non Small Cell Lung Cancer Trial in Philadelphia (Etirinotecan pegol
Completed
- Metastatic Non Small Cell Lung Cancer
- Recurrent Non Small Cell Lung Cancer
- Etirinotecan pegol (NKTR-102)
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 1, 2020
Recurrent Non Small Cell Lung Cancer Trial in Baltimore, Tiong Bahru Estate (Itraconazole, Pemetrexed)
Terminated
- Recurrent Non Small Cell Lung Cancer
-
Baltimore, Maryland
- +1 more
Jan 30, 2019
Recurrent Non Small Cell Lung Cancer Trial in United States (apricoxib/erlotinib, erlotinib/)
Completed
- Recurrent Non Small Cell Lung Cancer
- apricoxib/erlotinib
- erlotinib/placebo
-
Tucson, Arizona
- +46 more
Mar 13, 2012